
IndraLab
Statements
reach
"The loaded Auranofin in PCN224@Au could be released to down-regulate the deubiquitinating enzymes (e.g., CyclinB, USP14 and UCH37), blockade the deubiquitinating process and promote the accumulations of proteasomal substrate proteins (e.g., c-Jun and p21) to encourage proteasomal degradation of ubiquitinated target proteins."
reach
"In detail, Auranofin release from PCN224@Au down-regulated the deubiquitinating enzymes (e.g., CyclinB, USP14 and UCH37) and promoted the proteasomal substrate proteins (e.g., c-Jun and p21) accumulations via activating MAP3Ks, CDK and p53 pathways, which drove ubiquitinated target degradation by proteasome."
reach
"Auranofin (Aur) inhibits proteasome associated deubiquitinases (DUBs) UCHL5 and USP14 rather than the 20S proteasome; inhibition of the proteasome associated DUBs is required for Aur induced cytotoxicity; and Aur selectively inhibits tumor growth in vivo and induces cytotoxicity in cancer cells from patients with acute myeloid leukemia [XREF_BIBR]."